Kaushik Dave | Science 2.0

Kaushik J. Dave

Ph.D. in Pharmaceutical Chemistry from the University of Kansas and MBA from the Wharton School of the University of Pennsylvania. I am President and CEO of Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers.

What May Decide The Election May Not Be Abortion Or Inflation - It May Be Runaway Health Insurance Costs

When the federal government took over health care during the Obama years, a lot of promises were made while the concern when legislation was passed without knowing which parts of three competing…

If Your Favorite Brand Is Sincere, Is Innovation What You Expect?

EUGENE, Ore. -- April 25, 2016 -- Open the box of that new smartphone. Oops, it feels differently from expectations based on what you'd seen. Embrace it or be disappointed? Your reaction is likely…

Was FDA’s Recent Statement On BPA Premature?

A few weeks ago the U.S. National Toxicology Program (NTP) released the results of the largest study ever conducted on bisphenol A (BPA). The CLARITY Core study was conducted by

Environmental Campaigns Against Nuclear Science Limits Its Acceptance, Even In Thought Experiments On Reducing CO2

Can all nuclear energy be weaponized? It could, according to US politicians in the 1990s, when President Bill Clinton and Senator John Kerry mortally wounded nuclear energy development, to the cheers…

Test announcement

Kaushik J. Dave

More reads

What May Decide The Election May Not Be Abortion Or Inflation - It May Be Runaway Health Insurance Costs

If Your Favorite Brand Is Sincere, Is Innovation What You Expect?

Was FDA’s Recent Statement On BPA Premature?

Environmental Campaigns Against Nuclear Science Limits Its Acceptance, Even In Thought Experiments On Reducing CO2